NCT00004122View on ClinicalTrials.gov

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

April 30, 2001

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

BCG vaccine

BIOLOGICAL

recombinant interferon alfa

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER